Pharma Research Toronto (Pharma Research) is a division of Hoffmann-La Roche Limited that is engaged in discovering and developing antibody therapeutics to cure cancer and other diseases. It principally develops antibody therapeutics for the treatment of breast, prostate, ovarian, colorectal, pancreatic, lung cancers, leukemia, and melanoma diseases. Pharma Research identifies monoclonal antibodies targeting various cancer indications through its technology platform, FunctionFIRST. This technology generates and selects therapeutic antibodies based on their activity and before the antigen is known. The company has developed a broad range of functional antibodies which include a pipeline of more than 400 antibody drug products. Pharma Research is headquartered in Ontario, Canada.

Street: 
55 York Street
City: 
Toronto
Postcode: 
M5J 1R7
Federal State : 
Canada
WebSite: 
www.rochecanada.com/portal/eipf/ca/portal/roche/ph
Fax: 
1-416-8629696

Company Index Score

Current Index Score Historical Index Score
  • Pharma Research Toronto currently scores 50 % in the index.
  • Pharma Research Toronto is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Pharma Research Toronto is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets